Castle biosciences stock.

Key Insights Significantly high institutional ownership implies Castle Biosciences' stock price is sensitive to their...

Castle biosciences stock. Things To Know About Castle biosciences stock.

The stock price of Castle Biosciences, a skin cancer diagnostic company, has seen a large 24% drop over the last ten trading days, while it is down 14% over the last five trading days.Belgium, a country known for its rich history, stunning architecture, and vibrant culture, offers a plethora of attractions for visitors to explore. From medieval castles to modern art galleries, Belgium has something for everyone.On average, Wall Street analysts predict. that Castle Biosciences's share price could reach $32.13 by Aug 4, 2024. The average Castle Biosciences stock price prediction forecasts a potential upside of 63.57% from the current CSTL share price of $19.64.Health has made over 7 trades of the Castle Biosciences stock since 2019, according to the Form 4 filled with the SEC. Most recently Health sold 250,000 units of CSTL stock worth $8,625,000 on 12 May 2020.

Castle Biosciences (CSTL – Research Report), the Healthcare sector company, was revisited by a Wall Street analyst on November 2. Analyst Catherine Ramsey Schulte from Robert W. Baird remains ...

Castle Biosciences, Inc. is a commercial-stage diagnostics company. The Company is focused on providing physicians and their patients with personalized, clinically actionable information to clinicians and their patients to inform treatment decisions and improve health outcomes.Key Insights Significantly high institutional ownership implies Castle Biosciences' stock price is sensitive to their...

Nov 11, 2021 · The stock price of Castle Biosciences (NASDAQ: CSTL), a skin cancer diagnostic company, has seen a fall of over 9% last month, while it is down 12% in a week. The recent fall can be attributed to ... Dec 1, 2023 · Stock analysis for Castle Biosciences Inc (CSTL:NASDAQ GM) including stock price, stock chart, company news, key statistics, fundamentals and company profile. Castle Biosciences (CSTL – Research Report), the Healthcare sector company, was revisited by a Wall Street analyst on November 2. Analyst Catherine Ramsey Schulte from Robert W. Baird remains ...Miles has made over 2 trades of the Castle Biosciences stock since 2022, according to the Form 4 filled with the SEC. Most recently he exercised 3,825 units of CSTL stock worth $76,653 on 2 June 2023.Overview. Castle Biosciences is improving health through our innovative tests that guide patient care. For the diseases that our portfolio of tests cover, we believe …

Castle Biosciences, Inc. (CSTL) Stock Price | Stock Quote Nasdaq - MarketScreener CASTLE BIOSCIENCES, INC. PDF Report Castle Biosciences, Inc. Stock price …

Apr 5, 2022 · AltheaDx filed for an initial public stock offering in December 2014 but shelved the proposed stock sale in early 2015. Castle Biosciences, which went public in 2019, makes tests that help guide ...

Castle Biosciences Inc (CSTL) Stock Expected to Experience Positive Growth on November 3, 2023: Analysts Predictions and Ratings. On November 3, 2023, Castle Biosciences Inc (CSTL) stock is expected to experience positive growth, according to analysts. The 8 analysts offering 12-month price forecasts for CSTL have a median …Castle Biosciences, Inc. (NASDAQ:CSTL) Q2 2023 Earnings Call Transcript Cathie Wood's Top 15 Small-Cap Stock Picks Small Caps Begin to Rebound: 5 Stocks …thefly.com — Castle Biosciences raises FY23 revenue view to at least $200M, consensus $187.1M News • Nov 1, 2023 GamesIndustry.biz — Remedy posts flat revenue for Q3 2023Overview. Castle Biosciences is improving health through our innovative tests that guide patient care. For the diseases that our portfolio of tests cover, we believe the traditional approach to developing a treatment plan for cancers and other diseases using clinical and pathology factors alone is inadequate and can be improved by incorporating the personalized information our tests provide.The estimated Net Worth of Joseph C. Iii Cook is at least $56 Million dollars as of 18 March 2021. Mr. Cook owns over 12,229 units of Castle Biosciences stock worth over $2,473,211 and over the last 4 years he sold CSTL stock worth over $53,227,575. In addition, he makes $286,714 as Independent Director at Castle Biosciences.Jun. 03, 2022 5:05 PM ET Castle Biosciences, Inc. (CSTL) SA Transcripts. 140.86K Follower s. The following slide deck was published by Castle Biosciences, Inc. in conjunction with this event. View ...Revenue growth over the past 12 months for CASTLE BIOSCIENCES INC comes in at 55.17%, a number that bests 91.18% of the US stocks we're tracking. Stocks with similar financial metrics, market capitalization, and price volatility to CASTLE BIOSCIENCES INC are SILK, ONTF, IGC, FLGT, and BMRA. Visit CSTL's SEC page to see the company's …

Europe PMC is an archive of life sciences journal literature.Following this news, Relmada’s stock price fell nearly 80% to close at $6.48 per share on October 13, 2022. ... Castle Biosciences, Inc. (NASDAQ: CSTL)... stock price multiplied by the number of shares outstanding. Castle Biosciences net worth as of November 17, 2023 is $0.53B. Compare CSTL With Other Stocks ...Castle Biosciences, Inc. (NASDAQ:CSTL) Q2 2023 Earnings Call Transcript Cathie Wood's Top 15 Small-Cap Stock Picks Small Caps Begin to Rebound: 5 Stocks …Castle Biosciences’ technology approach objectively measures optimal combinations of epithelial, immune, and stromal processes in the context of tissue morphology to extract tissue profiles (information from digital whole side images of tissue biopsies) that are correlated with diagnosis and prognosis. Our tissue systems biology approach integrates …With stocks at historic highs, many individuals are wondering if the time is right to make their first foray in the stock market. The truth is, there is a high number of great stocks to buy today. However, you might be unsure how to begin.Europe PMC is an archive of life sciences journal literature.

May 30, 2023 · Castle Biosciences Inc Stock Price History. Castle Biosciences Inc’s price is currently up 8.79% so far this month. During the month of May, Castle Biosciences Inc’s stock price has reached a high of $26.70 and a low of $20.56. Over the last year, Castle Biosciences Inc has hit prices as high as $36.10 and as low as $15.58. Year to date ...

The Castle Biosciences, Inc. stock price gained 1.95% on the last trading day (Wednesday, 29th Nov 2023), rising from $19.48 to $19.86. During the last trading day the stock fluctuated 3.77% from a day low at $19.61 to a day high of $20.35. The price has risen in 7 of the last 10 days and is up by 3.76% over the past 2 weeks.Castle Biosciences today announced it has signed a definitive agreement to acquire Cernostics, Inc. ... which may consist entirely of cash or $20 million in cash and $10 million in common stock of ...Overview. Castle Biosciences is improving health through our innovative tests that guide patient care. For the diseases that our portfolio of tests cover, we believe …Under the terms of the definitive agreement, AltheaDx will become a wholly owned subsidiary of Castle Biosciences. At closing, Castle will pay $65.0 million in initial consideration to AltheaDx ...Europe PMC is an archive of life sciences journal literature. https://orcid.orgJun 15, 2023 · Shares of Castle Biosciences are trading down 1.98% over the last 24 hours, at $13.40 per share. A move to $30.00 would account for a 123.88% increase from the current share price. About Castle ... Whoopi Goldberg tested positive for Covid and will be absent from The View until she recovers. A day after it was confirmed she had fallen ill, the co-hosts of the ABC daytime talk show addressed ...The latest Castle Biosciences stock prices, stock quotes, news, and CSTL history to help you invest and trade smarter. Castle Biosciences, Inc. (NASDAQ:CSTL) Q2 2023 Earnings Call Transcript Cathie Wood's Top 15 Small-Cap Stock Picks Small Caps Begin to Rebound: 5 Stocks to Buy Now Castle Biosciences, Inc. (NASDAQ ...Discover historical prices for CSTL stock on Yahoo Finance. View daily, weekly or monthly format back to when Castle Biosciences, Inc. stock was issued.

Castle Biosciences Inc is a commercial-stage dermatological cancer company. It is focused on providing physicians and their patients with personalized, clinically actionable genomic information to make more accurate treatment decisions. The product portfolio of the company includes Cutaneous Melanoma, DecisionDx-Melanoma, DecisionDx-CMSeq, and ...

About the Castle Biosciences, Inc. stock forecast. As of 2023 November 23, Thursday current price of CSTL stock is 19.810$ and our data indicates that the asset price has been in a downtrend for the past 1 year (or since its inception).. Castle Biosciences stock price has been showing a declining tendency so we believe that …

Castle Biosciences-stock Castle Biosciences Inc Registered Shs Stock , CSTL 19.78 + +% After-market 04:20:00 PM NAS Add to watchlist 19.78 -0.10 -0.50% Official Close …Find real-time CSTL - Castle Biosciences Inc stock quotes, company profile, news and forecasts from CNN Business.Nov 30, 2023 · A high-level overview of Castle Biosciences, Inc. (CSTL) stock. Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and investment tools. 2 Ağu 2023 ... Castle Biosciences CSTL · Profile · Stock Chart · Financial Statements · Financial Ratios · Other stocks of industry "Diagnostics research" ...Castle Biosciences, Inc. (CSTL) came out with a quarterly loss of $0.77 per share versus the Zacks Consensus Estimate of a loss of $0.70. This compares to loss of $0.47 per share a year ago.NasdaqGM - NasdaqGM Real Time Price. Currency in USD Follow 2W 10W 9M 19.51 -0.27 (-1.37%) As of 03:38PM EST. Market open. 1d 5d 1m 6m YTD 1y 5y Max Full screen …Jul 13, 2023 · Shares of Castle Biosciences ( CSTL -7.22%) were down more than 20.2% for the week as of Thursday's close, according to data provided by S&P Global Market Intelligence. The healthcare stock closed ... Castle Biosciences stock declined 14% over a five-day trading period ending 3/10/2021, compared to a broader market (S&P500) rise of 2.3%; A change of -14% or more over five trading days is a 4% ...Jun 5, 2023 · Shares of Castle Biosciences ( CSTL 2.42%) were down more than 47% on Monday afternoon as three analysts lowered their price targets for the medical diagnostic stock. The healthcare stock is down ... Castle Biosciences (Nasdaq: CSTL) is a leading diagnostics company improving health through innovative tests that guide patient care. The Company aims to …Whoopi Goldberg tested positive for Covid and will be absent from The View until she recovers. A day after it was confirmed she had fallen ill, the co-hosts of the ABC daytime talk show addressed ...In the last 3 months, 12 analysts have offered 12-month price targets for Castle Biosciences. The company has an average price target of $34.83 with a high of $41.00 and a low of $25.00.

Castle Biosciences announced that it has completed its acquisition of AltheaDx, Inc. ... up to an additional $75.0 million in cash and common stock will be payable in connection with the ...Castle Biosciences Inc Stock Price History. Castle Biosciences Inc’s price is currently down 22.91% so far this month. During the month of October, Castle Biosciences Inc’s stock price has reached a high of $16.84 and a low of $12.07. Over the last year, Castle Biosciences Inc has hit prices as high as $29.59 and as low as $9.26. Year to ...White Castle does not allow for the purchase of franchises. Each of the restaurants is privately owned and operated through the White Castle parent company. Because the company is privately owned, it doesn’t offer stock options to the publi...Castle Biosciences, Inc. Doesn't appear a compelling earnings-beat candidate. However, investors should pay attention to other factors too for betting on this stock or staying away from it ahead ...Instagram:https://instagram. halliburton sharesev companiesrpihxbuy cricket phone Are you yearning for adventure, breathtaking landscapes, and a journey through history? Look no further than a tour of Scotland and Ireland. These two countries boast rich cultural heritage, stunning natural beauty, and countless attraction...Castle Biosciences Inc Stock Price History. Castle Biosciences Inc’s price is currently down 39.75% so far this month. During the month of June, Castle Biosciences Inc’s stock price has reached a high of $24.55 and a low of $9.26. Over the last year, Castle Biosciences Inc has hit prices as high as $36.10 and as low as $9.26. Year to date ... most volatile futuressep ira providers Castle Biosciences, Inc. (NASDAQ:CSTL) Q2 2023 Earnings Call Transcript Cathie Wood's Top 15 Small-Cap Stock Picks Small Caps Begin to Rebound: 5 Stocks … sjim price What exchange does Castle Biosciences trade on and what is the company’s stock symbol? Castle Biosciences’ stock is traded on The Nasdaq Global Market under the ticker symbol "CSTL". Nov 23, 2023 · Castle Biosciences Inc’s trailing 12-month revenue is $192.0 million with a -39.3% profit margin. Year-over-year quarterly sales growth most recently was 66.2%. Analysts expect adjusted earnings to reach $-2.723 per share for the current fiscal year. Castle Biosciences Inc does not currently pay a dividend. FRIENDSWOOD, Texas--(BUSINESS WIRE)--Castle Biosciences, Inc. ... Net loss for the third quarter, which includes non-cash stock-based compensation expense of $13.0 million, was $(6.9) million ...